Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD.
Kwazikwakhe B GabuzaThendo I MabudaOelfah PatelNoxolo KhuboniRuzayda van AardeSylvia RiedelNonhlakanipho F SangweniShantal WindvogelRabia JohnsonChristo John Frederick MullerPublished in: PloS one (2024)
Afriplex GRTTM reduced hepatic steatosis in oleic acid induced C3A liver cells by modulating SREBF1, ChREBP and IRS-1 gene expression. The extract may also play a role in alleviating inflammation by reducing TNF-α expression, suggesting that additional experiments are required for its development as a suitable therapeutic option against NAFLD. Importantly, further research is needed to explore its antioxidant role in this model.